Conagra Brands Inc

In early Stage 1 consolidation within a long-term downtrend, CAG has formed a fragile base marked by initial higher-lows and higher-highs, but price is extended above rising short-term EMAs and in overbought territory. Execution should be deferred, favoring pullbacks into the rising 9/21 EMA support zone for higher-probability entries.

• ↑Launching high-protein, GLP-1-friendly products to capture growing health-food demand.
• ↑Insiders Richard Lenny and John Mulligan bought at $14.30, boosting confidence.
• ↓Weak profitability factors; EPS expected to drop 17.8% YoY to $0.46.